Streetbeat News

Products Services

MSOS

VRNOF

Darren Weiss comments on the cannabis industry, noting that vape hasn't overtaken the flower sector. Companies need to diversify, covering all categories to meet consumer demands. Weiss highlights the potential in European and global markets for leveraging learning and innovation. He emphasizes the importance of scale, category focus, and brand development as competitive advantages.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:58 pm

COIN

Glassnode, in collaboration with Coinbase International (NASDAQ:COIN), released a Q2 crypto market guide focusing on Bitcoin (BTC) and Ethereum (ETH). The report highlights Bitcoin's historical performance, with an annualized return of 124% from 2013 to 2023, and significant volatility. It also notes the approval of spot Bitcoin ETFs by the SEC in January 2024, leading to record inflows. Ethereum's growth is attributed to upgrades and the expanding DeFi ecosystem, with a notable increase in the total value locked. Both cryptocurrencies have seen derivatives markets growth, with expectations of further activity due to the Bitcoin Halving and potential approval of Ether ETFs.

Portfolio Pulse from Khyathi Dalal

April 16, 2024 | 7:57 pm

KA

Kineta's stock price has increased following the announcement that the company has been granted a US patent for 'Proteasome activity enhancing compounds,' which includes methods for treating cancer or tumors.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:52 pm

GRAM

MSOS

Laurie Holcomb attributes a 6%-7% decrease in retail store revenues to the sale of hemp products, including D8 and D9, in smoke shops. Holcomb advocates for the sale of hemp products through regulated stores and channels.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:52 pm

MSOS

Constantin Von Der Groeben discussed the irreversible nature of cannabis legalization, indicating that no market has reversed legalization once it has been enacted. The context suggests a focus on the cannabis industry's growth and stability, particularly in markets where legalization has occurred. Access to a live Cannabis Capital Conference is offered for further insights.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:49 pm

MSOS

Constantin Von Der Groeben discusses collaboration with U.S. and Canadian companies, focusing on learning from U.S. firms, recognizing Germany's achievements, and identifying opportunities for growth. The context suggests a focus on the cannabis industry, highlighted by a mention of the Cannabis Capital Conference.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:48 pm

MSOS

VRNOF

Darren Weiss commented on achieving a higher ROI by focusing on a slower ramp and limiting offerings in specific markets. The context was provided during a discussion at the Cannabis Capital Conference, which is accessible to both existing and new subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:47 pm

ALVO

Alvotech has received FDA approval for Selarsdi, a treatment for moderate to severe plaque psoriasis and active psoriatic arthritis in both adult and pediatric patients. This approval marks a significant milestone for Alvotech, potentially impacting its market position and stock performance.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:46 pm

CURLF

MSOS

Matt Darin predicts significant global development in the coming years, with a particular emphasis on rapid growth in the Australia market and New Zealand. The Cannabis Capital Conference offers live access for existing and new subscribers to explore these trends further.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:44 pm

GRAM

MSOS

Laurie Holcomb highlights the rapid pace of change in the cannabis market, noting that cake strains were popular a year or two ago, but now the trend has shifted towards candy strains. Companies need to adapt quickly to stay in the market.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:42 pm